Genesis Therapeutics

Genesis Therapeutics headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery. The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled...

Deep learning,drug discovery,artificial intelligence,and drug development

Genesis therapeutics operates in the Biotechnology research industry.

Genesis therapeutics's revenue is 11m - 100m

Genesis therapeutics has 51 - 200 employees.